Proton beam therapy

What it is

Proton beam therapy is a type of radiation therapy that uses protons instead of traditional X-rays to kill cancer cells. It works by delivering a precise dose of radiation directly to the tumor site, minimizing damage to surrounding healthy tissue.

What research shows

Studies suggest that proton beam therapy can be effective in treating various types of cancer, including pediatric orbital rhabdomyosarcoma, lung cancer, and chondrosarcoma, with favorable outcomes such as high overall survival rates and low toxicity. For example, a study found that children with orbital rhabdomyosarcoma had a 10-year overall survival rate of >85% with multimodal therapy, including proton beam therapy.

Current status

Proton beam therapy is a valuable treatment option for certain types of cancer, particularly those that are sensitive to radiation and have a high risk of recurrence. However, more research is needed to fully understand its benefits and limitations, and to determine its optimal use in clinical practice.

Key studies

• PMID 42569952

  Children with orbital rhabdomyosarcoma had a 10-year overall survival rate of >85% with multimodal therapy, including proton beam therapy.

  PubMed ↗
• PMID 42535416

  Proton beam therapy was effective in treating chordomas and chondrosarcomas of the skull base, with favorable outcomes and low toxicity.

  PubMed ↗
• PMID 42512274

  Proton therapy was associated with lower lung density changes compared to photon therapy in breast cancer patients.

  PubMed ↗
• PMID 42507318

  An automated evaluation system for lattice radiotherapy using a commercial treatment planning system scripting API was developed.

  PubMed ↗
• PMID 42494366

  Tegoprazan was found to be noninferior to pantoprazole in preventing post-endoscopic submucosal dissection bleeding.

  PubMed ↗